JANUARY 07, 2020
MINNEAPOLIS, Jan. 7, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems website. Currently all serum and media products can be purchased through R&D Systems.
Dave Eansor, President of Bio-Techne’s Protein Sciences Segment, commented, “We are excited to consolidate the Atlanta Biologicals portfolio within R&D Systems’ extended offering of cell culture solutions. By rolling the Atlanta Biologicals brand into R&D Systems, researchers will benefit from ensured product quality, an expanded portfolio of culture regents and an experience that enables the purchase of media, serum, proteins, antibodies, and more from a single, trusted source.”
More information on the rebranding and retirement of Atlanta Biologicals can be found at https://www.rndsystems.com/atlanta-biologicals-now-rd-systems
About Bio-Techne Corporation (NASDAQ: TECH)
| Contact: | David Clair, Senior Director, Corporate Development |
| david.clair@bio-techne.com | |
| 612-656-4416 |